These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20531464)

  • 1. Fetal dopamine receptor characteristics assessed in utero.
    Bartlett RM; Dejesus OT; Barnhart TE; Nickles RJ; Christian BT; Graner JL; Holden JE
    J Cereb Blood Flow Metab; 2010 Aug; 30(8):1437-40. PubMed ID: 20531464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderate-level prenatal alcohol exposure alters striatal dopamine system function in rhesus monkeys.
    Schneider ML; Moore CF; Barnhart TE; Larson JA; DeJesus OT; Mukherjee J; Nickles RJ; Converse AK; Roberts AD; Kraemer GW
    Alcohol Clin Exp Res; 2005 Sep; 29(9):1685-97. PubMed ID: 16205369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraversion and striatal dopaminergic receptor availability in young adults: an [18F]fallypride PET study.
    Baik SH; Yoon HS; Kim SE; Kim SH
    Neuroreport; 2012 Mar; 23(4):251-4. PubMed ID: 22257904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride.
    Slifstein M; Kegeles LS; Xu X; Thompson JL; Urban N; Castrillon J; Hackett E; Bae SA; Laruelle M; Abi-Dargham A
    Synapse; 2010 May; 64(5):350-62. PubMed ID: 20029833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy.
    Yakushev IY; Dupont E; Buchholz HG; Tillmanns J; Debus F; Cumming P; Heimann A; Fellgiebel A; Luhmann HJ; Landvogt C; Werhahn KJ; Schreckenberger M; Potschka H; Bartenstein P
    Epilepsia; 2010 Mar; 51(3):415-22. PubMed ID: 19694792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.
    Mukherjee J; Yang ZY; Brown T; Lew R; Wernick M; Ouyang X; Yasillo N; Chen CT; Mintzer R; Cooper M
    Nucl Med Biol; 1999 Jul; 26(5):519-27. PubMed ID: 10473190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of receptor-ligand binding potential in sub-striatal domains using probabilistic and template regions of interest.
    del Campo N; Tait RJ; Acosta-Cabronero J; Hong YT; Izquierdo-Garcia D; Smith R; Aigbirhio FI; Sahakian BJ; Müller U; Robbins TW; Fryer TD
    Neuroimage; 2011 Mar; 55(1):101-12. PubMed ID: 21126591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics.
    Rominger A; Cumming P; Xiong G; Koller G; Böning G; Wulff M; Zwergal A; Förster S; Reilhac A; Munk O; Soyka M; Wängler B; Bartenstein P; la Fougère C; Pogarell O
    Addict Biol; 2012 Mar; 17(2):490-503. PubMed ID: 22023291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G; Landvogt C; Vernaleken I; Buchholz HG; Ondracek J; Siessmeier T; Härtter S; Schreckenberger M; Stoeter P; Hiemke C; Rösch F; Wong DF; Bartenstein P
    Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in amphetamine-induced displacement of [(18)F]fallypride in striatal and extrastriatal regions: a PET study.
    Riccardi P; Zald D; Li R; Park S; Ansari MS; Dawant B; Anderson S; Woodward N; Schmidt D; Baldwin R; Kessler R
    Am J Psychiatry; 2006 Sep; 163(9):1639-41. PubMed ID: 16946193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography (PET) imaging of nicotine-induced dopamine release in squirrel monkeys using [
    Naylor JE; Hiranita T; Matazel KS; Zhang X; Paule MG; Goodwin AK
    Drug Alcohol Depend; 2017 Oct; 179():254-259. PubMed ID: 28818716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D2 receptor binding with [123I]epidepride SPECT.
    Ichise M; Fujita M; Seibyl JP; Verhoeff NP; Baldwin RM; Zoghbi SS; Rajeevan N; Charney DS; Innis RB
    J Nucl Med; 1999 Nov; 40(11):1902-12. PubMed ID: 10565788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [(18)F]fallypride in nonhuman primates.
    Christian BT; Narayanan TK; Shi B; Mukherjee J
    Synapse; 2000 Oct; 38(1):71-9. PubMed ID: 10941142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.
    Dresel S; Mager T; Rossmüller B; Meisenzahl E; Hahn K; Möller HJ; Tatsch K
    Eur J Nucl Med; 1999 Aug; 26(8):862-8. PubMed ID: 10436199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [125I]iodopride: a specific high affinity radioligand for labelling striatal dopamine D-2 receptors.
    Janowsky A; De Paulis T; Clanton JA; Smith HE; Ebert MH; Kessler RM
    Eur J Pharmacol; 1988 May; 150(1-2):203-5. PubMed ID: 3402540
    [No Abstract]   [Full Text] [Related]  

  • 17. Dynamic imaging of striatal D2 receptors in mice using quad-HIDAC PET.
    Honer M; Brühlmeier M; Missimer J; Schubiger AP; Ametamey SM
    J Nucl Med; 2004 Mar; 45(3):464-70. PubMed ID: 15001689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.
    Vandehey NT; Moirano JM; Converse AK; Holden JE; Mukherjee J; Murali D; Nickles RJ; Davidson RJ; Schneider ML; Christian BT
    J Cereb Blood Flow Metab; 2010 May; 30(5):994-1007. PubMed ID: 20040928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouse.
    Rominger A; Mille E; Böning G; Wängler B; Josef Gildehaus F; Arszol C; Bartenstein P; Cumming P
    Synapse; 2010 Aug; 64(8):654-7. PubMed ID: 20336625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride.
    Riccardi P; Baldwin R; Salomon R; Anderson S; Ansari MS; Li R; Dawant B; Bauernfeind A; Schmidt D; Kessler R
    Biol Psychiatry; 2008 Jan; 63(2):241-4. PubMed ID: 17586476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.